Dr. Michele Andrews: Introducing the Myopia Management Conversation

Michele Andrews, OD, Senior Director of North America Professional & Academic Affairs at CooperVision, discusses how clinicians can—and why they should—talk about the progression of myopia with parents. The Brilliant Futures™ Myopia Management Program provides guidance on ways to include these conversations.

Indications for Use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.